Intersect ENT, Inc. et al. vs. New Amsterdam, LLC
Explore the PTAB proceeding IPR2024-00713 filed by Intersect ENT, Inc. et al. on 2024-03-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2024-00713
Filing Date
2024-03-25
Accorded Filing Date
2024-03-25
Institution Decision Date
—
Last Modified Date
2024-06-27
Proceeding Type
IPR
Termination Date
2024-06-21
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Intersect ENT, Inc. et al.
Represented By
Wittenzellner, Johnet alPatent Owner / Respondent
New Amsterdam, LLC
Represented By
Fuller, Michaelet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32431 | Andrew Parfomak | +1 212-808-0700 |
| 33141 | Kurt Briscoe | +1 212-808-0700 |
| 33531 | Bruce Londa | +1 212-808-0700 |
| 48641 | Brian Anscomb | +1 312-218-8212 |
| 56750 | David Siegel | +1 212-557-7200 |
| 59139 | Joseph Farco | +1 212-415-7967 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,916,483 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,824,699 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2006024610 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.